Re: Chicharros USA - bolsa internacional
MDSI estoy investigando comparto pq es curioso, se dedican a hacer cámeras digitales
tipo sport , anunciaron
merge a finales agosto con una pharma! privada con una
droga contra el celiaquismo con fase 2 superada que empezará la fase 3 finales 2017, al parecer la pharma quiere saliren bolsa ahorrando costes y tiempo. La compañia perderá su nombre y cogerá el de Innovative pharma. Monster digital se vendera o separará, y antes del merge parece que quieren hacer r/s. En resumen que si las condiciones son adecuadas antes de 2018 MSDI pasará a ser otro ticker y una pharma en fase 3.
"Commenting on the potential Merger, Innovate CEO Christopher P. Prior, Ph.D., stated: "After significantly expanding our pipeline with the addition of the only late-stage drug for celiac disease, I believe the next logical step in our corporate development is having our stock quoted in a public market. We believe that the greater access to capital and overall visibility afforded by operating as a publicly-traded organization should play a role in our ability to advance our clinical pipeline, as well as continue to in-license and develop drugs for autoimmune/inflammation diseases.
"Once the deal closes, Innovate shareholders will end up owning 91% of the combined company with the remaining 9% going to Monster Digital Inc. (NASDAQ:MSDI) shareholders on a pro-forma basis. Early in the month, Innovate Director of Operations and Investor Relations Kendyle Woodward reiterated that a reverse merger would make the merger less expensive than if they had to file for an IPO.Innovate management will head the combined company and will operate under the name Innovate Biopharmaceuticals Inc. The combined company will trade on the NASDAQ under a new ticker.
“Management believes this is an exciting opportunity, to fulfill what we perceive is a significant unmet need and an opportunity to bring value creation to the combined company’s shareholders,”
said Innovate CEO, Christopher P Prior
Monster Digital CEO David H. Clarke added, "Our Board of Directors and management believe that a merger with Innovate is the best option for our company. Upon a definitive merger agreement being signed and prior to the Closing, we anticipate that the Monster Digital operating business will be sold or spun off into a separate company."
Before closing the merger, Monster will seek shareholder approval to conduct a
reverse split of its outstanding shares to satisfy listing requirements of the Nasdaq Capital Market (NasdaqCM). The combined company is to trade on the NasdaqCM under a new ticker symbol.
The companies expect the transaction to close in 2017, subject to approvals by the stockholders of Monster and Innovate, and other customary closing conditions.
